Iqvia price target raised to $266 from $250 at Mizuho

Mizuho raised the firm’s price target on Iqvia (IQV) to $266 from $250 and keeps an Outperform rating on the shares. The firm updated targets in the healthcare facilities and managed care group as part of a Q4 preview. Mizuho’s physician survey indicated healthcare utilization growth trends decelerated sequentially despite easier year-over-year comps, which could indicate trend is peaking, the analyst tells investors in a research note.